Published in Mol Cell Biol on November 01, 2005
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci U S A (2007) 2.77
Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem (2008) 2.53
Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J (2012) 2.36
Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J Lipid Res (2007) 2.21
Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models. Dis Model Mech (2009) 2.16
Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem (2011) 1.96
The function of α-synuclein. Neuron (2013) 1.63
Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. Mol Cell Proteomics (2008) 1.46
Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice. Diabetes (2009) 1.45
Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res (2008) 1.44
Docosahexaenoic acid (DHA) and hepatic gene transcription. Chem Phys Lipids (2008) 1.30
Lipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria. J Neurochem (2008) 1.29
Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification. Exp Cell Res (2008) 1.29
Shotgun lipidomics reveals the temporally dependent, highly diversified cardiolipin profile in the mammalian brain: temporally coordinated postnatal diversification of cardiolipin molecular species with neuronal remodeling. Biochemistry (2008) 1.16
Mass-spectrometry based oxidative lipidomics and lipid imaging: applications in traumatic brain injury. J Neurochem (2010) 1.14
Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism. PLoS One (2010) 1.13
Polyunsaturated fatty acids induce alpha-synuclein-related pathogenic changes in neuronal cells. Am J Pathol (2007) 1.08
Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome. J Lipid Res (2013) 1.06
The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition. J Biol Chem (2010) 1.05
Mitochondrial dysfunction in heart failure. Heart Fail Rev (2013) 1.02
Acyl coenzyme A thioesterase 7 regulates neuronal fatty acid metabolism to prevent neurotoxicity. Mol Cell Biol (2013) 1.02
Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases. Biochim Biophys Acta (2009) 1.01
Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with alpha-synuclein genotype. J Neurochem (2009) 1.01
Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism. Biochemistry (2006) 1.00
Mitochondrial quality control and neurological disease: an emerging connection. Expert Rev Mol Med (2010) 0.98
The Synaptic Function of α-Synuclein. J Parkinsons Dis (2015) 0.98
α-Synuclein and mitochondria: partners in crime? Neurotherapeutics (2013) 0.95
Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson disease. J Biol Chem (2009) 0.94
Emerging roles of cardiolipin remodeling in mitochondrial dysfunction associated with diabetes, obesity, and cardiovascular diseases. J Biomed Res (2010) 0.93
Interaction of α-synuclein with vesicles that mimic mitochondrial membranes. Biochim Biophys Acta (2011) 0.93
Myocardial regulation of lipidomic flux by cardiolipin synthase: setting the beat for bioenergetic efficiency. J Biol Chem (2012) 0.93
A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration. J Neurosci (2015) 0.92
Modulation of alpha-synuclein expression in transgenic animals for modelling synucleinopathies--is the juice worth the squeeze? Neurotox Res (2008) 0.91
The phospholipid monolayer associated with perilipin-enriched lipid droplets is a highly organized rigid membrane structure. Am J Physiol Endocrinol Metab (2011) 0.91
Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors. BMC Neurosci (2008) 0.91
Mitochondrial dysfunction in genetic animal models of Parkinson's disease. Antioxid Redox Signal (2011) 0.90
Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress. Cell Mol Life Sci (2010) 0.89
α-Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia. Dev Neurosci (2010) 0.88
Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network. FEBS Open Bio (2014) 0.88
Convergence of Parkin, PINK1, and α-Synuclein on Stress-induced Mitochondrial Morphological Remodeling. J Biol Chem (2015) 0.86
Impairment of mitochondria in adult mouse brain overexpressing predominantly full-length, N-terminally acetylated human α-synuclein. PLoS One (2013) 0.86
Brain mitochondrial lipid abnormalities in mice susceptible to spontaneous gliomas. Lipids (2008) 0.86
In vitro growth environment produces lipidomic and electron transport chain abnormalities in mitochondria from non-tumorigenic astrocytes and brain tumours. ASN Neuro (2009) 0.86
Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First? Parkinsons Dis (2015) 0.86
Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.86
α-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease. J Biol Chem (2015) 0.85
The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease. J Neurochem (2016) 0.85
Mitochondria: A Therapeutic Target for Parkinson's Disease? Int J Mol Sci (2015) 0.85
Α-synuclein neuropathology is controlled by nuclear hormone receptors and enhanced by docosahexaenoic acid in a mouse model for Parkinson's disease. Brain Pathol (2011) 0.84
Lipid classes and fatty acid patterns are altered in the brain of γ-synuclein null mutant mice. Lipids (2010) 0.84
Sphingolipids in human synovial fluid--a lipidomic study. PLoS One (2014) 0.84
αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson's Disease? Parkinsons Dis (2012) 0.84
Dynamics of Human Mitochondrial Complex I Assembly: Implications for Neurodegenerative Diseases. Front Mol Biosci (2016) 0.83
Lipopolysaccharide-induced blood brain barrier permeability is enhanced by alpha-synuclein expression. Neurosci Lett (2013) 0.83
Glucocorticoid modulation of mitochondrial function in hepatoma cells requires the mitochondrial fission protein Drp1. Antioxid Redox Signal (2012) 0.81
Lipid dysfunction and pathogenesis of multiple system atrophy. Acta Neuropathol Commun (2014) 0.79
Cell Biology and Pathophysiology of α-Synuclein. Cold Spring Harb Perspect Med (2017) 0.79
High expression of α-synuclein in damaged mitochondria with PLA2G6 dysfunction. Acta Neuropathol Commun (2016) 0.78
Interaction of α-synuclein and a cell penetrating fusion peptide with higher eukaryotic cell membranes assessed by ¹⁹F NMR. Mol Pharm (2012) 0.78
Brain disposition of α-Synuclein: roles of brain barrier systems and implications for Parkinson's disease. Fluids Barriers CNS (2014) 0.78
Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease. FEBS Lett (2015) 0.78
Biophysical characterization of α-synuclein and its controversial structure. Intrinsically Disord Proteins (2013) 0.78
A keratin scaffold regulates epidermal barrier formation, mitochondrial lipid composition, and activity. J Cell Biol (2015) 0.78
Effects of microwave radiation on brain energy metabolism and related mechanisms. Mil Med Res (2015) 0.78
Membrane lipid profile alterations are associated with the metabolic adaptation of the Caco-2 cells to aglycemic nutritional condition. J Bioenerg Biomembr (2014) 0.77
The regulation of catalase activity by PPAR γ is affected by α-synuclein. Ann Clin Transl Neurol (2014) 0.77
Prolongation of Chemically-Induced Methemoglobinemia in Mice Lacking α-synuclein: A Novel Pharmacologic and Toxicologic Phenotype. Toxicol Rep (2015) 0.76
Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent Neurons. eNeuro (2017) 0.75
Cardiolipin promotes electron transport between ubiquinone and complex I to rescue PINK1 deficiency. J Cell Biol (2017) 0.75
γ-synuclein is a novel player in the control of body lipid metabolism. Adipocyte (2013) 0.75
Imaging mass spectrometry reveals loss of polyunsaturated cardiolipins in the cortical contusion, hippocampus, and thalamus after traumatic brain injury. J Neurochem (2016) 0.75
Mitochondrial lipids in neurodegeneration. Cell Tissue Res (2016) 0.75
Mitochondrial bioenergetics decay in aging: beneficial effect of melatonin. Cell Mol Life Sci (2017) 0.75
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80
Molecular pathways of neurodegeneration in Parkinson's disease. Science (2003) 7.55
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron (2000) 6.92
Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids (1966) 6.31
Lipid extraction of tissues with a low-toxicity solvent. Anal Biochem (1978) 6.13
Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem (1998) 5.81
Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J (2000) 4.81
Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem (1990) 4.03
Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci (2002) 4.01
Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem (2002) 3.61
The biosynthesis and functional role of cardiolipin. Prog Lipid Res (2000) 3.60
Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem (2003) 3.16
Mitochondrial calcium transport: physiological and pathological relevance. Am J Physiol (1994) 3.14
Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol (2001) 3.00
Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J Biol Chem (2002) 2.92
The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci (1998) 2.78
Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A (2002) 2.64
Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions. Proc Natl Acad Sci U S A (2004) 2.62
Failure to produce mitochondrial DNA results in embryonic lethality in Rnaseh1 null mice. Mol Cell (2003) 2.60
Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein. J Biol Chem (2001) 2.49
Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J Biol Chem (1998) 1.84
Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins. Prog Lipid Res (2004) 1.83
X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am J Med Genet A (2004) 1.82
alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc Natl Acad Sci U S A (2001) 1.80
Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins. Biochemistry (1998) 1.80
Remodeling of cardiolipin by phospholipid transacylation. J Biol Chem (2003) 1.69
A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res Brain Res Rev (1993) 1.51
The essentiality of n-3 fatty acids for the development and function of the retina and brain. Annu Rev Nutr (1988) 1.44
Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J Neurochem (2004) 1.33
Mitochondrial dysfunction of a cultured Chinese hamster ovary cell mutant deficient in cardiolipin. J Biol Chem (1993) 1.33
Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology (2005) 1.31
Structural determinants of PLD2 inhibition by alpha-synuclein. J Mol Biol (2004) 1.29
Alpha-synuclein association with phosphatidylglycerol probed by lipid spin labels. Biochemistry (2003) 1.19
Brain lipid metabolism in the cPLA2 knockout mouse. J Lipid Res (2003) 1.18
Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. J Mol Neurosci (2001) 1.18
Molecular order and dynamics in bilayers consisting of highly polyunsaturated phospholipids. Biophys J (1998) 1.12
Acyl-CoA synthetase 2 overexpression enhances fatty acid internalization and neurite outgrowth. J Biol Chem (2004) 1.12
Alpha-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of alpha-synuclein palmitate binding. Biochemistry (2005) 1.11
Initial incorporation into rat liver glycerolipids of intraportally injected (3H)glycerol. Biochim Biophys Acta (1970) 1.10
Measuring the quantity and activity of mitochondrial electron transport chain complexes in tissues of central nervous system using blue native polyacrylamide gel electrophoresis. Anal Biochem (2000) 1.07
Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies. J Biol Chem (2003) 1.06
Threshold effects in synaptosomal and nonsynaptic mitochondria from hippocampal CA1 and paramedian neocortex brain regions. J Neurochem (1997) 1.05
Complex expression pattern of the Barth syndrome gene product tafazzin in human cell lines and murine tissues. Biochem Cell Biol (2004) 1.03
Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport. J Mol Neurosci (2001) 1.03
Fluorescence studies suggest a role for alpha-synuclein in the phosphatidylinositol lipid signaling pathway. Biochemistry (2005) 1.02
Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background. Neurobiol Aging (2005) 1.02
Saturation kinetics of coenzyme Q in NADH and succinate oxidation in beef heart mitochondria. FEBS Lett (1992) 1.01
Assessing functional integrity of mitochondria in vitro and in vivo. Methods Cell Biol (2001) 1.01
Fatty acid-binding proteins of nervous tissue. J Mol Neurosci (2001) 1.01
Fatty acid incorporation is decreased in astrocytes cultured from alpha-synuclein gene-ablated mice. J Neurochem (2005) 0.98
Fatty acid transport and utilization for the developing brain. J Neurochem (1998) 0.98
Rate-limiting step in electron transport. Osmotically sensitive diffusion of quinones through voids in the bilayer. J Biol Chem (1993) 0.96
Fatty acid binding protein: stimulation of microsomal phosphatidic acid formation. Arch Biochem Biophys (1997) 0.96
Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio. Biochim Biophys Acta (2003) 0.95
Fatty acid uptake and incorporation in brain: studies with the perfusion model. J Mol Neurosci (2001) 0.95
A critical appraisal of the mitochondrial coenzyme Q pool. FEBS Lett (2001) 0.95
An improved method for tissue long-chain acyl-CoA extraction and analysis. J Lipid Res (2004) 0.95
Stretch sensitivity of transmembrane mobility of hydrogen peroxide through voids in the bilayer. Role of cardiolipin. J Biol Chem (1994) 0.93
The effects of lipid phase transitions on the interaction of mitochondrial NADH--ubiquinone oxidoreductase with ubiquinol--cytochrome c oxidoreductase. Biochem J (1979) 0.91
Heart fatty acid uptake is decreased in heart fatty acid-binding protein gene-ablated mice. J Biol Chem (2004) 0.89
Cellular transport of nonesterified fatty acids. J Mol Neurosci (2001) 0.89
Lipid composition in synaptic and nonsynaptic mitochondria from rat brains and effect of aging. J Neurochem (1992) 0.88
The effects of lipid fluidity on the rotational diffusion of complex I and complex III in reconstituted NADH-cytochrome c oxidoreductase. Biochim Biophys Acta (1982) 0.87
Sterol carrier protein-2 expression alters phospholipid content and fatty acyl composition in L-cell fibroblasts. J Lipid Res (2000) 0.84
Dietary fatty acid composition induces comparable changes in cardiolipin fatty acid profile of heart and brain mitochondria. Lipids (1996) 0.82
A spin label study of the lipid boundary layer of mitochondrial NADH-ubiquinone oxidoreductase. Biochim Biophys Acta (1982) 0.82
Dietary essential fatty acids change the fatty acid profile of rat neural mitochondria over time. J Nutr (1991) 0.81
Brain uptake and utilization of fatty acids: applications to peroxisomal biogenesis diseases. J Mol Neurosci (2001) 0.77
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med (2013) 22.73
NT5E mutations and arterial calcifications. N Engl J Med (2011) 8.71
Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol (2008) 5.24
Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet (2008) 4.87
ClinGen--the Clinical Genome Resource. N Engl J Med (2015) 4.45
Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet Med (2012) 4.04
Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci (2002) 4.01
Structure and dynamics of micelle-bound human alpha-synuclein. J Biol Chem (2004) 3.87
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA (2012) 3.85
Chromosome catastrophes involve replication mechanisms generating complex genomic rearrangements. Cell (2011) 3.03
Detection of clinically relevant exonic copy-number changes by array CGH. Hum Mutat (2010) 2.93
Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat Med (2002) 2.90
Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase. Mamm Genome (2002) 2.79
Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet Med (2006) 2.78
Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum. Mol Genet Metab (2011) 2.65
Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein. J Biol Chem (2001) 2.49
Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model. Gene (2007) 2.01
Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem (2011) 1.96
Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol Dis (2006) 1.96
Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov Disord (2006) 1.93
Dent Disease with mutations in OCRL1. Am J Hum Genet (2004) 1.81
Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin. J Gen Intern Med (2009) 1.77
Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. Arch Neurol (2005) 1.72
Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PLoS One (2009) 1.71
Phosphoinositide profiling in complex lipid mixtures using electrospray ionization mass spectrometry. Nat Biotechnol (2003) 1.64
Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure. EMBO J (2004) 1.62
Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency. J Biol Chem (2004) 1.56
Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy. Pediatr Blood Cancer (2011) 1.55
Manipulation of cholesterol levels in rod disk membranes by methyl-beta-cyclodextrin: effects on receptor activation. J Biol Chem (2002) 1.53
Recurrent partial rhombencephalosynapsis and holoprosencephaly in siblings with a mutation of ZIC2. Am J Med Genet A (2011) 1.49
The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization. Am J Hum Genet (2002) 1.47
Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. Mol Cell Proteomics (2008) 1.46
Redefined genomic architecture in 15q24 directed by patient deletion/duplication breakpoint mapping. Hum Genet (2009) 1.46
Creatine metabolism in combined methylmalonic aciduria and homocystinuria. Ann Neurol (2005) 1.46
The development of a highly informative mouse Simple Sequence Length Polymorphism (SSLP) marker set and construction of a mouse family tree using parsimony analysis. Genome Res (2003) 1.44
Chromosome 8p23.1 deletions as a cause of complex congenital heart defects and diaphragmatic hernia. Am J Med Genet A (2009) 1.40
High-fat diet-induced juvenile obesity leads to cardiomyocyte dysfunction and upregulation of Foxo3a transcription factor independent of lipotoxicity and apoptosis. J Hypertens (2006) 1.39
Expression of Rem2, an RGK family small GTPase, reduces N-type calcium current without affecting channel surface density. J Neurosci (2005) 1.38
Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene. Hum Genet (2003) 1.38
Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol Cell Neurosci (2003) 1.37
Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res (2009) 1.36
Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics (2013) 1.36
Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet (2010) 1.36
Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice. J Clin Invest (2010) 1.33
GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. Mol Genet Metab (2008) 1.33
Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene. Am J Hum Genet (2005) 1.30
An improved LC-MS/MS procedure for brain prostanoid analysis using brain fixation with head-focused microwave irradiation and liquid-liquid extraction. J Lipid Res (2008) 1.30
Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification. Exp Cell Res (2008) 1.29
Self-healing collodion membrane and mild nonbullous congenital ichthyosiform erythroderma due to 2 novel mutations in the ALOX12B gene. Arch Dermatol (2008) 1.27
Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets. J Neurochem (2006) 1.26
Proposed guidelines for papers describing DNA polymorphism-disease associations. Hum Genet (2002) 1.25
Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation. Mol Genet Metab (2012) 1.24
Utility of oligonucleotide array-based comparative genomic hybridization for detection of target gene deletions. Clin Chem (2008) 1.21
Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain. Hum Mol Genet (2009) 1.21
Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am J Clin Nutr (2008) 1.21
Contribution of membrane elastic energy to rhodopsin function. Biophys J (2010) 1.21
Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects. Genet Med (2010) 1.18
Congenital disorder of glycosylation (CDG)-Ih patient with a severe hepato-intestinal phenotype and evolving central nervous system pathology. J Pediatr (2005) 1.18
Deletion and duplication of 15q24: molecular mechanisms and potential modification by additional copy number variants. Genet Med (2010) 1.18
Structure and orientation of a G protein fragment in the receptor bound state from residual dipolar couplings. J Mol Biol (2002) 1.17
Early-onset severe neuromuscular phenotype associated with compound heterozygosity for OPA1 mutations. Mol Genet Metab (2011) 1.13
Citrin deficiency, a perplexing global disorder. Mol Genet Metab (2008) 1.12
Alpha-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of alpha-synuclein palmitate binding. Biochemistry (2005) 1.11
Alpha-synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids. J Neurochem (2007) 1.11
Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders. Mol Genet Metab (2012) 1.11
Lipid-rhodopsin hydrophobic mismatch alters rhodopsin helical content. J Am Chem Soc (2008) 1.10
Clinical and positron emission tomography of Parkinson's disease caused by LRRK2. Ann Neurol (2005) 1.09
Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol (2014) 1.08
Brain neutral lipids mass is increased in alpha-synuclein gene-ablated mice. J Neurochem (2007) 1.07
Alpha-synuclein expression modulates microglial activation phenotype. J Neurosci (2006) 1.07
Phenotypic manifestations of copy number variation in chromosome 16p13.11. Eur J Hum Genet (2010) 1.06
LC/MS/MS method for analysis of E₂ series prostaglandins and isoprostanes. J Lipid Res (2011) 1.06
Regulation of membrane proteins by dietary lipids: effects of cholesterol and docosahexaenoic acid acyl chain-containing phospholipids on rhodopsin stability and function. Biophys J (2008) 1.05
Molecular bases and clinical spectrum of early infantile epileptic encephalopathies. Eur J Med Genet (2012) 1.05
Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J Clin Invest (2012) 1.05
Baking reduces prostaglandin, resolvin, and hydroxy-fatty acid content of farm-raised Atlantic salmon (Salmo salar). J Agric Food Chem (2011) 1.04
The role of alpha-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response. Mol Cell Biochem (2008) 1.04
Brief report: autistic symptoms, developmental regression, mental retardation, epilepsy, and dyskinesias in CNS folate deficiency. J Autism Dev Disord (2007) 1.03
Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity. PLoS One (2012) 1.03
Prevalence of Parkinson's disease in populations of African ancestry: a review. J Natl Med Assoc (2004) 1.02
Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background. Neurobiol Aging (2005) 1.02
Recurrent deletions and reciprocal duplications of 10q11.21q11.23 including CHAT and SLC18A3 are likely mediated by complex low-copy repeats. Hum Mutat (2011) 1.01
Epimerase-deficiency galactosemia is not a binary condition. Am J Hum Genet (2005) 1.00
Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism. Biochemistry (2006) 1.00
Ménage-à-trois 1 is critical for the transcriptional function of PPARgamma coactivator 1. Cell Metab (2007) 1.00
Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency. Liver Transpl (2008) 1.00
Transition to next generation analysis of the whole mitochondrial genome: a summary of molecular defects. Hum Mutat (2013) 0.99
Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency. Hum Mutat (2010) 0.98
Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments. J Biol Chem (2004) 0.98
A single nucleotide polymorphism in the 3'UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease. Neurosci Lett (2009) 0.98
Regulation of phagocytosis in Dictyostelium by the inositol 5-phosphatase OCRL homolog Dd5P4. Traffic (2007) 0.97
An improved method for tissue long-chain acyl-CoA extraction and analysis. J Lipid Res (2004) 0.95
Clinical phenotype and candidate genes for the 5q31.3 microdeletion syndrome. Am J Med Genet A (2012) 0.95
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro. J Neuroinflammation (2011) 0.95
Expression profiling reveals multiple myelin alterations in murine succinate semialdehyde dehydrogenase deficiency. J Inherit Metab Dis (2006) 0.95